FR3120792B1 - Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition - Google Patents

Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition Download PDF

Info

Publication number
FR3120792B1
FR3120792B1 FR2102728A FR2102728A FR3120792B1 FR 3120792 B1 FR3120792 B1 FR 3120792B1 FR 2102728 A FR2102728 A FR 2102728A FR 2102728 A FR2102728 A FR 2102728A FR 3120792 B1 FR3120792 B1 FR 3120792B1
Authority
FR
France
Prior art keywords
treatment
composition
skin hyperpigmentation
cosmetic composition
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2102728A
Other languages
English (en)
Other versions
FR3120792A1 (fr
Inventor
Jean-Christophe Anton
Denis Marin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cryonove Pharma
Original Assignee
Cryonove Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR2102728A priority Critical patent/FR3120792B1/fr
Application filed by Cryonove Pharma filed Critical Cryonove Pharma
Priority to US18/550,957 priority patent/US20240148425A1/en
Priority to EP22715023.2A priority patent/EP4308246A1/fr
Priority to JP2023556513A priority patent/JP2024510614A/ja
Priority to PCT/EP2022/056600 priority patent/WO2022194810A1/fr
Priority to BR112023018573A priority patent/BR112023018573A2/pt
Priority to CN202280021925.7A priority patent/CN117157050A/zh
Publication of FR3120792A1 publication Critical patent/FR3120792A1/fr
Application granted granted Critical
Publication of FR3120792B1 publication Critical patent/FR3120792B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/95—Involves in-situ formation or cross-linking of polymers

Abstract

La présente invention concerne, d’une part, une composition cosmétique destinée à une application sur l’épiderme pour le traitement de l’hyperpigmentation cutanée, caractérisée en ce qu’elle comprend de 1 à 7 doses d’un fluide cryogénique pulvérisé dont la température d’ébullition est comprise entre -196°C et -19°C, chaque dose étant comprise entre 0,048 mL et 0,56 mL et, d’autre part, une méthode de préparation in situ de ladite composition ainsi qu’un procédé de traitement cosmétique utilisant ladite composition. Figure de l’abrégé : Fig. 4
FR2102728A 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition Active FR3120792B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR2102728A FR3120792B1 (fr) 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
EP22715023.2A EP4308246A1 (fr) 2021-03-18 2022-03-15 Composition cosmétique destinée au traitement de l'hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
JP2023556513A JP2024510614A (ja) 2021-03-18 2022-03-15 皮膚の色素沈着の治療を意図した化粧品組成物及び当該組成物を使用する治療方法
PCT/EP2022/056600 WO2022194810A1 (fr) 2021-03-18 2022-03-15 Composition cosmétique destinée au traitement de l'hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
US18/550,957 US20240148425A1 (en) 2021-03-18 2022-03-15 Cosmetic composition intended for the treatment of skin hyperpigmentation and treatment method using said composition
BR112023018573A BR112023018573A2 (pt) 2021-03-18 2022-03-15 Composição cosmética, método para preparar uma composição cosmética, e, uso da composição cosmética
CN202280021925.7A CN117157050A (zh) 2021-03-18 2022-03-15 用于治疗皮肤色素沉着的美容组合物和使用该组合物的治疗方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2102728 2021-03-18
FR2102728A FR3120792B1 (fr) 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition

Publications (2)

Publication Number Publication Date
FR3120792A1 FR3120792A1 (fr) 2022-09-23
FR3120792B1 true FR3120792B1 (fr) 2024-03-22

Family

ID=77913143

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2102728A Active FR3120792B1 (fr) 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition

Country Status (7)

Country Link
US (1) US20240148425A1 (fr)
EP (1) EP4308246A1 (fr)
JP (1) JP2024510614A (fr)
CN (1) CN117157050A (fr)
BR (1) BR112023018573A2 (fr)
FR (1) FR3120792B1 (fr)
WO (1) WO2022194810A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100087806A1 (en) * 2008-10-07 2010-04-08 Vandolay, Inc. Automated Cryogenic Skin Treatment
EP3045132A1 (fr) 2015-01-13 2016-07-20 Starpharm Traitement cosmétique des taches brunes cutanées
FR3076200B1 (fr) * 2017-12-28 2023-04-14 Cryobeauty Pharma Buse d'application pour dispositif de traitement dermo-cosmetique des taches brunes cutanees par cryotherapie cyto-selective

Also Published As

Publication number Publication date
CN117157050A (zh) 2023-12-01
WO2022194810A1 (fr) 2022-09-22
WO2022194810A4 (fr) 2022-11-10
EP4308246A1 (fr) 2024-01-24
BR112023018573A2 (pt) 2023-11-28
FR3120792A1 (fr) 2022-09-23
JP2024510614A (ja) 2024-03-08
US20240148425A1 (en) 2024-05-09

Similar Documents

Publication Publication Date Title
Chen et al. Acupuncture or acupressure at the Sanyinjiao (SP6) acupoint for the treatment of primary dysmenorrhea: a meta-analysis
Schott Reflex sympathetic dystrophy
Cao et al. Acupoint stimulation for fibromyalgia: a systematic review of randomized controlled trials
Gregory et al. Parkinson's disease and the skin
Russo et al. A novel compound analgesic cream (ketamine, pentoxifylline, clonidine, DMSO) for complex regional pain syndrome patients
Dawson et al. Acetaminophen use and change in blood pressure in a hypertensive population
Boyd et al. The role of capsaicin in dermatology
FR3120792B1 (fr) Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
Zhang et al. An overview of systematic reviews of randomized controlled trials on acupuncture treating migraine
Koumaki et al. Palmoplantar pustulosis-like eruption induced by baricitinib for treatment of rheumatoid arthritis
Carroll et al. Management of chronic pain following nerve injuries/CRPS type II
FR3095658B1 (fr) Procédé de soin cosmétique à base d’extraits photoactifs de microalgues
Park et al. Literature Review on Parkinson's disease in Oriental medicine
Buntinx et al. Development of an in vivo target‐engagement biomarker for TRPA1 antagonists in humans
Sundaresan et al. Treatment of leg veins for restless leg syndrome: a retrospective review
Vélez Ozone therapy, a supplement for patients with fibromyalgia
Zhang et al. Acupuncture for premature ejaculation: a systematic review and meta-analysis
Verri et al. Effects of chronic type 5 phosphodiesterase inhibition on penile microvascular reactivity in hypertensive patients with erectile dysfunction: a randomized crossover placebo-controlled trial
FR3117371B1 (fr) Extrait de Mitracarpus scaber et son utilisation pour améliorer la fonction barrière et favoriser l’hydratation de la peau
Smirnova et al. Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low-and moderate-risk patients: data from 10-year follow-up
Zhu et al. Efficacy of scraping therapy on blood pressure and sleep quality in stage I and II essential hypertension: a systematic review and meta-analysis
Qureshi et al. Raynaud’s disease and clinical challenges: a minireview of literature with a spotlight on acupuncture
Skibitsky et al. Antihypertensive and vasoprotective effectiveness of the chronopharmacotherapy in patients with arterial hypertension after acute cerebrovascular accident
Ben et al. Effect of Trichilia monadelpha (Thonn.) JJ de Wilde (Meliaceae) extracts on C-reactive proteins levels and acute inflammation
Shestakova et al. Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220923

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4